From: Validation of the pooled cohort risk score in an Asian population – a retrospective cohort study
Clinical characteristics | 1998 | 2007 |
---|---|---|
Age, year (mean) | 57.5 ± 8.8 | 67.5 ± 8.8 |
Sex, female (n, %) | 615 (66.7) | 615 (66.7) |
Ethnicity (n, %) | ||
- Malay | 210 (22.7) | 210 (22.7) |
- Chinese | 425 (46.1) | 425 (46.1) |
- Indian | 275 (29.8) | 275 (29.8) |
- Others | 12 (1.4) | 12 (1.4) |
Diabetes mellitus (n, %) | 424 (47.0) | 528 (57.3) |
- HbA1c, % (mean) | 7.7 ± 1.8 | 7.5 ± 1.6 |
- DM controlled with HbA1c ≤6.5% (n, %) | 110 (11.9) | 163 (17.7) |
Systolic BP, mmHg (mean) | 140.9 ± 18.6 | 135.1 ± 16.6 |
- Use of anti-hypertensive agents (n, %) | 552 (59.9) | 760 (82.4) |
- BP controlled SBP ≤140 mmHg (n, %) | 568 (61.6) | 681 (73.9) |
- RAS blocker use (n, %) | 66 (7.2) | 371 (40.2) |
Total cholesterol, mg/dl (mean) | 234.8 ± 42.3 | 190.9 ± 37.2 |
HDL cholesterol, mg/dl (mean) | 47.6 ± 14.2 | 49.6 ± 12.5 |
LDL cholesterol, mg/dl (mean) | 143.1 ± 40.7 | 115.5 ± 31.6 |
Statin use in 1998 (n, %) | 90 (9.7) | 587 (63.7) |
Smoker (n, %) | 56 (6.1) | 56 (6.1) |